1. Home
  2. FLXS vs RAPT Comparison

FLXS vs RAPT Comparison

Compare FLXS & RAPT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • FLXS
  • RAPT
  • Stock Information
  • Founded
  • FLXS 2001
  • RAPT 2015
  • Country
  • FLXS United States
  • RAPT United States
  • Employees
  • FLXS N/A
  • RAPT N/A
  • Industry
  • FLXS Home Furnishings
  • RAPT Biotechnology: Pharmaceutical Preparations
  • Sector
  • FLXS Consumer Discretionary
  • RAPT Health Care
  • Exchange
  • FLXS Nasdaq
  • RAPT Nasdaq
  • Market Cap
  • FLXS 175.4M
  • RAPT 194.2M
  • IPO Year
  • FLXS N/A
  • RAPT 2019
  • Fundamental
  • Price
  • FLXS $46.30
  • RAPT $11.38
  • Analyst Decision
  • FLXS
  • RAPT Buy
  • Analyst Count
  • FLXS 0
  • RAPT 5
  • Target Price
  • FLXS N/A
  • RAPT $33.60
  • AVG Volume (30 Days)
  • FLXS 34.4K
  • RAPT 107.2K
  • Earning Date
  • FLXS 08-18-2025
  • RAPT 08-07-2025
  • Dividend Yield
  • FLXS 1.73%
  • RAPT N/A
  • EPS Growth
  • FLXS 85.86
  • RAPT N/A
  • EPS
  • FLXS 3.55
  • RAPT N/A
  • Revenue
  • FLXS $441,073,000.00
  • RAPT N/A
  • Revenue This Year
  • FLXS $5.24
  • RAPT N/A
  • Revenue Next Year
  • FLXS $4.50
  • RAPT N/A
  • P/E Ratio
  • FLXS $13.05
  • RAPT N/A
  • Revenue Growth
  • FLXS 6.86
  • RAPT N/A
  • 52 Week Low
  • FLXS $29.38
  • RAPT $5.67
  • 52 Week High
  • FLXS $65.87
  • RAPT $26.56
  • Technical
  • Relative Strength Index (RSI)
  • FLXS 73.19
  • RAPT 54.94
  • Support Level
  • FLXS $44.06
  • RAPT $10.06
  • Resistance Level
  • FLXS $46.72
  • RAPT $11.65
  • Average True Range (ATR)
  • FLXS 2.18
  • RAPT 0.88
  • MACD
  • FLXS 1.00
  • RAPT 0.02
  • Stochastic Oscillator
  • FLXS 88.74
  • RAPT 77.43

About FLXS Flexsteel Industries Inc.

Flexsteel Industries Inc is a United States-based company that manufactures, imports, and markets residential upholstered wooden furniture products. Its product offerings include sofas, loveseats, chairs, rockers, desks, tables, convertible bedding units, and bedroom furniture. The company's products are intended for use in home, office, hotel, healthcare, and other contract applications. A featured component in the company's upholstered furniture is the durable Blue Steel Spring. It operates in the business segment of Furniture products. The company's furniture products business involves the distribution of manufactured and imported products for residential markets.

About RAPT RAPT Therapeutics Inc.

RAPT Therapeutics Inc is a clinical-stage immunology-based biopharmaceutical company. It is focused on discovering, developing, and commercializing oral small-molecule therapies for patients with some unmet needs in oncology and inflammatory diseases. The company pipeline products include FLX475, designed to selectively inhibit the migration of immunosuppressive regulatory T cells into tumors; and RPT193, designed to selectively inhibit the migration of type 2 T helper cells into inflamed tissues.

Share on Social Networks: